Ambeed.cn

首页 / 抑制剂/激动剂 / / 阿片受体 / PZM21

PZM21 {[allProObj[0].p_purity_real_show]}

货号:A821297

PZM21是一种强效且选择性的 μ 阿片受体激动剂,EC50 为 1.8 nM。

PZM21 化学结构 CAS号:1997387-43-5
PZM21 化学结构
CAS号:1997387-43-5
PZM21 3D分子结构
CAS号:1997387-43-5
PZM21 化学结构 CAS号:1997387-43-5
PZM21 3D分子结构 CAS号:1997387-43-5
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

PZM21 纯度/质量文件 产品仅供科研

货号:A821297 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 Opioid receptor ORL1 μ-opioid receptor 其他靶点 纯度
Racecadotril 98%
JTC-801 ++

Opioid receptor-like1 (ORL1), IC50: 94 nM

98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

PZM21 生物活性

描述 PZM21 is a potent and selective μ opioid receptor agonist with an EC50 of 1.8 nM.

PZM21 细胞实验

Cell Line
Concentration Treated Time Description References
LAD2 human mast cells 0.1 to 10 µM 2 hours Evaluate the effect of PZM21 on mast cell degranulation; results showed no significant effect Anesthesiology. 2019 Jul;131(1):132-147
HEK 293 cells 1- 30000 nM 2 minutes (Gi activation) and 10 minutes (arrestin-3 translocation) Measure the effects of PZM21 on Gi protein activation and arrestin-3 translocation in HEK 293 cells. Results showed PZM21 is a low efficacy agonist for both Gi activation and arrestin-3 translocation. Br J Pharmacol. 2018 Jul;175(13):2653-2661
Mouse Embryonic Fibroblasts (MEFs) 0.03 to 30 µM 48 hours Evaluate the effect of PZM21 on fibroblast proliferation; results showed no significant effect Anesthesiology. 2019 Jul;131(1):132-147

PZM21 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Rhesus macaques Acute thermal nociception and drug self-administration model Subcutaneous and intrathecal 1.0-6.0 mg/kg (subcutaneous), 0.03-0.3 mg (intrathecal) Single administration, observed for 5 hours To evaluate the antinociceptive effects, drug self-administration behavior, and pruritic effects of PZM21. Results showed PZM21 had similar antinociceptive effects and abuse potential as oxycodone, and intrathecal administration induced significant itch scratching. Br J Anaesth. 2020 Oct;125(4):596-604
Mice C57BL/6J mice Subcutaneous injection 10 mg/kg, 20 mg/kg, 40 mg/kg Single administration PZM21 displayed dose-dependent analgesia in a mouse hotplate assay, with a per cent maximal possible effect (% MPE) of 87% reached 15 min after administration of the highest dose of drug tested (40 mg/kg). The highest dose of morphine tested plateaued at 92% after 30 min. Intriguingly, no analgesic effect was observed for PZM21 in the tail-flick assay. PZM21 solely confers analgesia to the affective component of pain, with minimal effect on the reflexive component. Additionally, PZM21 was devoid of both respiratory depression and morphine-like reinforcing activity in mice at equi-analgesic doses. Nature. 2016 Sep 8;537(7619):185-190
Mice (C57BL and CD-1) Awake, freely moving mice Intraperitoneal (i.p.) and subcutaneous (s.c.) injection 10–80 mg/kg Single dose or twice daily administration for 3-5 days Evaluate the effects of PZM21 on respiration and antinociception. Results showed PZM21 dose-dependently depressed respiration, similar to morphine. Repeated administration induced tolerance to antinociception but not to respiratory depression. Br J Pharmacol. 2018 Jul;175(13):2653-2661
CD-1 mice Acetic acid-induced writhing model, hot-water tail withdrawal test, formalin-induced paw licking assay Intravenous injection 20 mg/kg (intravenous injection) Single dose Evaluate the analgesic effects of the compounds. Results showed that compounds 6a, 6f, 6h, and 6k exhibited analgesia rates exceeding 97% in the acetic acid-induced writhing model, compounds 6a, 6b, and 6h showed significant antinociceptive action in the hot-water tail withdrawal test, and compounds 6a, 6f, and 6h exhibited prolonged antinociceptive effects in the formalin-induced paw licking assay Molecules. 2024 Jun 21;29(13):2961
ICR mice Formalin injection nociception assay and writhing test Subcutaneous injection 20 mg/kg and 40 mg/kg (formalin injection assay), 10 mg/kg (writhing test) Single dose To evaluate the analgesic effects of PZM21 and its analogues, PZM21 showed 77.9% and 92.8% analgesia in the formalin injection assay at 20 mg/kg and 40 mg/kg, respectively. Molecules. 2019 Jan 11;24(2):259
Mice and rats Thermal antinociception tests, conditioned place preference test, locomotor sensitization test, precipitated withdrawal test, self-administration test Intraperitoneal or intrathecal 20, 40, or 80 mg/kg (i.p.); 2.5, 5, or 7.5 μg (intrathecal) Single or repeated administration, lasting from hours to days PZM21 exhibited antinociceptive efficacy, without rewarding or reinforcing properties. However, repeated administration led to antinociceptive tolerance and naloxone-precipitated withdrawal symptoms. PZM21 also enhanced morphine-induced antinociception and attenuated the expression of morphine reward. Br J Pharmacol. 2019 Dec;176(23):4434-4445
Adult male Hartley guinea pigs Lumbar intrathecal catheter connected to osmotic pump model Intrathecal infusion 28 nmol/hour Continuous for 14 days Evaluate the effect of PZM21 on spinal mass formation in vivo; results showed no mass formation Anesthesiology. 2019 Jul;131(1):132-147

PZM21 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.77mL

0.55mL

0.28mL

13.83mL

2.77mL

1.38mL

27.66mL

5.53mL

2.77mL

PZM21 技术信息

CAS号1997387-43-5
分子式C19H27N3O2S
分子量 361.5
SMILES Code O=C(N[C@@H](C)CC1=CSC=C1)NC[C@@H](N(C)C)CC2=CC=C(O)C=C2
MDL No. MFCD30802176
别名
运输蓝冰
InChI Key MEDBIJOVZJEMBI-YOEHRIQHSA-N
Pubchem ID 121596705
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Keep in dark place, sealed in dry, 2-8°C

溶解方案

DMSO: 105 mg/mL(290.46 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。